Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-29
1993-11-23
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546306, C07D21102, A61K 3144
Patent
active
052644456
ABSTRACT:
This compound provides the compound (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine, its salts and pharmaceutical formulations, and its method of use for opening potassium channels in mammals.
REFERENCES:
patent: 4057636 (1977-11-01), Petersen et al.
FASEB Journal, 3(3), A435 (1989) (Abstract 1214).
Peterson et al., J. Med. Chem., 21 (8), 773 (1978).
Westin et al., Drugs, 36 (Supp. 7), 10 (1988).
Robertson David W.
Steinberg Mitchell I.
Conrad Robert A.
Davis Zinna N.
Eli Lilly and Company
Ivy C. Warren
Whitaker Leroy
LandOfFree
(-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849126